ICU Map
Organ System0% Site Mastery

Neurocritical Care

Intracranial hypertension, severe TBI, ischemic stroke, status epilepticus, and brain death.

Mastery
0%
Core Topics
12
0 completed
Clinical Problems
19
Bedside guides
Physiology
3
Concepts & loops
Clinical Cases
7
0 solved
Medications
35
Profiles & pearls

Core Topics

12 topics
neurology

Altered Consciousness, Coma, & Delirium in the ICU

ARAS neuroanatomy, structural vs toxic-metabolic coma, the comprehensive Coma Exam (pupils, cold calorics, posturing), FOUR score, and CAM-ICU delirium.

neurology

Status Epilepticus

Recognition and time-sensitive escalation of care for prolonged or repeated seizures.

neurology

Intracranial Hypertension & Cerebral Edema

Monro-Kellie doctrine, ICP waveforms (P2>P1, Lundberg A-waves), CPP targets (60–70 mmHg), herniation syndromes, and the 4-tier BTF management protocol.

neurology

Brain Death / Death by Neurologic Criteria (BD/DNC)

2023 AAN/AAP/CNS/SCCM consensus guideline: prerequisites, brainstem reflex examination, apnea testing on and off ECMO, valid ancillary tests, plus separate post-declaration donor-management principles.

neurology

Acute Ischemic Stroke

Core vs penumbra dynamics, ASPECTS & CT perfusion, Tenecteplase/Alteplase thrombolysis, DAWN/DEFUSE 3 extended thrombectomy, BP targets, and malignant MCA hemicraniectomy.

neurology

Intracranial Hemorrhage: ICH & SAH

Spontaneous ICH vs Aneurysmal SAH, INTERACT-2/ATACH-2 blood pressure targets, emergency anticoagulant reversal, ENRICH minimally invasive evacuation, ISAT coiling, and Nimodipine for delayed cerebral ischemia.

neurology

Severe Traumatic Brain Injury

Severe TBI neurocritical care: prevent hypoxemia/hypotension, treat intracranial hypertension, individualize ventilation/CPP, use evidence-based short antiseizure prophylaxis when chosen, and escalate surgery when indicated.

neurology

Acute Meningitis & Encephalitis

CT-before-LP criteria, CSF interpretation matrix, de Gans Dexamethasone timing, empiric age/host antimicrobial coverage + Ampicillin + Acyclovir, and neurocritical ICP management.

neurology

ICU Sedation, Analgesia, Delirium & Liberation

Analgesia-first sedation, light sedation targets, ABCDEF bundle, spontaneous breathing trials, and non-pharmacologic delirium mitigation.

neurology

ICU-Acquired Weakness (CIP/CIM)

Critical illness polyneuropathy and myopathy: recognition, risk reduction, diagnostic approach, ventilator liberation, rehabilitation, and prognosis.

neurology

Myasthenia Gravis & Myasthenic Crisis

Dedicated ICU management of myasthenic crisis: respiratory mechanics, airway timing, IVIG/plasma exchange, trigger control, medication hazards, and extubation.

neurology

Guillain–Barré Syndrome (GBS)

Dedicated ICU GBS care: respiratory surveillance, autonomic instability, IVIG/plasma exchange, airway strategy, pain/DVT prevention, and complications.

Clinical Problems & Bedside Triage

19 guides
Bedside Guide

Acute Hypercapnia & Ventilatory Failure

Triaging rising PaCO2: distinguishing acute uncompensated acidemia from chronic compensation, identifying central vs pump vs dead-space failure, and titrating noninvasive ventilation.

Bedside Guide

New Bradycardia & Conduction Blocks

Acute bradyarrhythmia management: identifying hemodynamic instability, distinguishing sinus node arrest vs high-grade AV block, medical chronotropic support (atropine, epinephrine), and emergent pacing.

Bedside Guide

Acute Severe Hypertension & Hypertensive Emergencies

Differentiating hypertensive emergency (acute target organ damage) from asymptomatic hypertension: tailored pressure targets for SCAPE, aortic dissection, hemorrhagic stroke, and ischemic stroke.

Bedside Guide

Acute Altered Mental Status & ICU Delirium

Systematic neurologic evaluation: immediate metabolic/toxic screening (glucose, hypoxia, hypercapnia), nonconvulsive status epilepticus exclusion, structural CT triage, and CAM-ICU delirium management.

Bedside Guide

New Focal Neurologic Deficit in the ICU

Rapid code-stroke protocol in critical illness: emergent non-contrast CT and CTA, distinguishing acute ischemic stroke (LVO candidate) from intracranial hemorrhage, and managing post-procedural neurological loss.

Bedside Guide

New Seizure & Status Epilepticus

Time-critical stepped seizure protocol: immediate airway/oxygen/glucose check, first-line IV benzodiazepines at 5 minutes, second-line non-sedating AEDs at 10–20 minutes, and general anesthetic induction at 30 minutes for refractory status.

Bedside Guide

Acute Coma & Loss of Brainstem Reflexes

Bedside evaluation of profound unresponsiveness: FOUR score and GCS, pupillary/corneal/caloric reflex examination, herniation syndrome recognition, confounder clearance, and Death by Neurologic Criteria (BD/DNC) evaluation.

Bedside Guide

Rapidly Progressive Weakness / Impending Ventilatory Failure

Bedside assessment and airway decision-making in rapidly ascending or fatiguable weakness risking ventilatory pump failure.

Bedside Guide

Severe Symptomatic Hyponatremia

Treat severe neurologic symptoms with controlled 3% saline boluses, then prevent overcorrection by separating the immediate symptom target from the 24-hour safety ceiling.

Bedside Guide

Severe Hypernatremia & Water Deficit

Bedside evaluation of severe hypernatremia: free-water deficit, ongoing losses, central vs nephrogenic diabetes insipidus, volume resuscitation, and individualized monitored sodium correction.

Bedside Guide

New Fever in the ICU & Suspected Infection

Systematic diagnostic workup of new ICU fever (T ≥ 38.3°C): line and device screening, pulmonary/abdominal/urinary source triage, distinguishing infectious vs non-infectious fever, and rational blood culturing.

Bedside Guide

Persistent Fever Despite Broad-Spectrum Antibiotics

Evaluating unresolved fever after 48–72 hours of antimicrobial therapy: undrained closed-space infection, resistant/fungal pathogens, catheter infections, C. difficile, drug fever, and ICU thrombosis.

Bedside Guide

Immunocompromised Patient with Fever + Organ Failure

Bedside diagnostic framing and emergency management of acute fever, sepsis, respiratory failure, or oncologic emergency in an immunocompromised host.

Bedside Guide

Critically Ill Pregnant or Postpartum Patient

Maternal-first stabilization with rapid differentiation of hypertensive, hemorrhagic, thromboembolic, septic, hepatic and cardiac obstetric emergencies.

Bedside Guide

Progressive Weakness with Impending Respiratory Failure

Use trajectory, bulbar function and respiratory mechanics to intubate before arrest and choose disease-specific therapy.

Bedside Guide

Severe Withdrawal With Agitation or Seizures

Hyperadrenergic delirium, hallucinations or seizures after alcohol/benzodiazepine reduction.

Bedside Guide

Agitation After Antipsychotic Exposure: QT Risk, EPS or NMS?

A complication-first bedside problem for an ICU patient exposed to antipsychotics who develops worsening agitation, rigidity, hyperthermia or electrical instability.

Bedside Guide

Raised ICP / Impending Herniation

Rapid neurologic deterioration with suspected intracranial hypertension requiring immediate physiologic stabilization, hyperosmolar rescue and urgent definitive neuroimaging/neurosurgical treatment.

Bedside Guide

Severe or Recurrent Hypoglycemia

Neuroglycopenia or recurrent low glucose requiring immediate glucose restoration, recurrence prevention and rapid investigation of drug, organ-failure, endocrine and nutritional causes.

Physiology Modules & Waveforms

3 concepts
Physiology

Cerebral Perfusion Pressure: CPP = MAP − ICP Dynamics

In the healthy brain, Cerebral Autoregulation maintains a constant Cerebral Blood Flow (CBF) across a wide range of CPP (50–150 mmHg) by dynamic arteriolar vasoconstriction and vasodilation. In severe traumatic brain injury, subarachnoid hemorrhage, or intracranial hypertension, autoregulation is frequently impaired or shifted rightward. Cerebral blood flow becomes passively dependent on perfusion pressure. When ICP rises (e.g., to 35 mmHg) and MAP is low or normal (e.g., 75 mmHg), CPP drops to 40 mmHg, below the critical ischemic threshold. Microvascular collapse occurs in the ischemic penumbra surrounding the brain contusion, triggering cellular ATP depletion, cytotoxic edema, and secondary brain infarction. Conversely, excessive CPP (>70–80 mmHg) drives vasogenic edema and increases the incidence of Acute Respiratory Distress Syndrome (ARDS).

Physiology

Osmoregulation, ADH & Free Water Balance

Hypothalamic osmoreceptors detect changes in tonicity as small as 1%. When Posm exceeds 285 mOsm/kg, pituitary ADH release triggers insertion of aquaporin-2 water channels into collecting duct apical membranes, concentrating urine (Uosm > 600–800 mOsm/kg) and conserving free water. Non-osmotic stimuli (arterial baroreceptor unloading from hypovolemia, heart failure, cirrhosis, sepsis, pain, nausea, and stress) override osmotic inhibition. In these states, ADH is secreted even when serum osmolality is low, resulting in impaired free water excretion and dilutional hyponatremia if hypotonic fluids are administered.

Physiology

Central DI vs Osmotic Diuresis Differentiation

In Central Diabetes Insipidus (e.g. post-transsphenoidal pituitary surgery, severe TBI, brain death), absolute deficiency of pituitary ADH prevents aquaporin-2 insertion in the collecting duct. The kidney cannot concentrate urine: urine is maximally dilute (Uosm < 100–200 mOsm/kg, specific gravity < 1.005), leading to rapid hypernatremic dehydration if free water is not replaced. In Osmotic Diuresis (e.g. DKA/HHS with glycosuria, post-mannitol administration, or urea excretion during post-AKI recovery), unreabsorbed high-concentration luminal solutes create an osmotic gradient that drags water and electrolytes along the tubule. Urine osmolality is isotonic or moderately concentrated (Uosm > 300 mOsm/kg), and total daily solute excretion is markedly elevated.

Clinical Reasoning Cases

7 cases
R4 case

Refractory Status Epilepticus (RSE)

Persistent status epilepticus after adequate benzodiazepine and second-line antiseizure therapy

R4 case

Acute Intracranial Hypertension Crisis

Tiered management of intracranial hypertension after severe traumatic brain injury

R3 case

Severe Symptomatic Hyponatremia with Seizures

Emergency hypertonic saline, close sodium monitoring, and prevention/rescue of overcorrection

R2 case

Central Diabetes Insipidus / Arginine Vasopressin Deficiency

Post-operative water-balance emergency after pituitary surgery

R1 case

Convulsive Status Epilepticus: First Contact

Immediate stabilization, adequate benzodiazepine dosing, and evidence-based second-line therapy

R5 case

Mechanical Mitral Valve with Intracerebral Hemorrhage

Emergency VKA reversal followed by individualized anticoagulation resumption

R5 case

Acute Liver Failure with Cerebral-Edema Risk

Hyperammonemia, osmotherapy, CRRT, and neuroprotection during transplant evaluation

Medications & Pharmacology

35 monographs
hematologic
Alteplase
Thrombolytic / Recombinant Tissue Plasminogen Activator
antimicrobials
Amikacin
Aminoglycoside Antibiotic
antimicrobials
Ceftriaxone
3rd-Generation Cephalosporin Antibiotic
neuromuscular-blockers
Cisatracurium
Non-Depolarizing Benzylisoquinolinium NMBA
antihypertensives-vasodilators
Clevidipine
Ultra-Short-Acting Dihydropyridine Calcium Channel Blocker
corticosteroids
Dexamethasone
Long-Acting Synthetic Fluorinated Glucocorticoid (High Anti-Inflammatory Potency) with Negligible Mineralocorticoid Activity
sedatives-analgesics
Dexmedetomidine
Selective Alpha-2 Adrenergic Agonist
sedatives-analgesics
Fentanyl
Synthetic Mu-Opioid Receptor Agonist
neurological
Fosphenytoin
Water-Soluble Phenytoin Prodrug / Voltage-Gated Sodium Channel Blocker
hematologic
4-Factor Prothrombin Complex Concentrate
Hemostatic Agent / Clotting Factor Concentrate
sedatives-analgesics
Hydromorphone
Semi-Synthetic Mu-Opioid Receptor Agonist
fluid-electrolyte
Hypertonic Saline (3%)
Hyperosmolar Agent / Concentrated Electrolyte Solution
sedatives-analgesics
Ketamine
Dissociative NMDA Receptor Antagonist
antihypertensives-vasodilators
Labetalol
Combined Alpha-1 and Non-Selective Beta Blocker
neurological
Levetiracetam
Second-Generation Antiepileptic / SV2A Ligand
antimicrobials
Linezolid
Oxazolidinone Antibiotic
fluid-electrolyte
Mannitol
Osmotic Diuretic / Hyperosmolar Agent
antimicrobials
Metronidazole
Synthetic Nitroimidazole Antimicrobial
sedatives-analgesics
Midazolam
Short-Acting Benzodiazepine
antihypertensives-vasodilators
Nicardipine
Dihydropyridine Calcium Channel Blocker
sedatives-analgesics
Propofol
Intravenous Sedative-Hypnotic Agent
neuromuscular-blockers
Rocuronium
Non-Depolarizing Aminosteroid Neuromuscular Blocking Agent
neuromuscular-blockers
Succinylcholine
Depolarizing Neuromuscular Blocking Agent
neurological
Valproate (IV)
Broad-Spectrum Antiepileptic / GABA Transaminase Inhibitor
hematologic
Idarucizumab
Dabigatran-specific antibody fragment
hematologic
Tenecteplase
Fibrinolytic
cardiovascular
Aspirin
Antiplatelet agent
cardiovascular
Clopidogrel
P2Y12 inhibitor
antimicrobials
Acyclovir
Antiviral nucleoside analogue
sedatives-analgesics
Haloperidol
First-generation (typical) antipsychotic
sedatives-analgesics
Quetiapine
Second-generation (atypical) antipsychotic
sedatives-analgesics
Olanzapine
Second-generation (atypical) antipsychotic
sedatives-analgesics
Ziprasidone
Second-generation (atypical) antipsychotic
sedatives-analgesics
Risperidone
Second-generation (atypical) antipsychotic
hematologic
Intravenous Immune Globulin (IVIG)
Pooled Human IgG Immunomodulator